Nasalcrom and Bronchitis - a phase IV clinical study of FDA data

Summary:

Bronchitis is reported as a side effect among people who take Nasalcrom (cromolyn sodium), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Zoloft, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Bronchitis when taking Nasalcrom. It is created by eHealthMe based on reports of 1,489 people who have side effects when taking Nasalcrom from the FDA, and is updated regularly.

What is Nasalcrom?

Nasalcrom has active ingredients of cromolyn sodium. It is often used in allergies. eHealthMe is studying from 1,528 Nasalcrom users. Check the latest studies of Nasalcrom.

What is Bronchitis?

Bronchitis (inflammation of the mucous membrane in the bronchial tubes) is found to be associated with 2,328 drugs and 2,440 conditions by eHealthMe. Check the latest studies of Bronchitis.

On Jul, 17, 2026

1,489 people reported to have side effects when taking Nasalcrom.
Among them, 22 people (1.48%) have Bronchitis.

Among these 22 people:

How long have people been on Nasalcrom when they have Bronchitis? *

What is the gender of people who have Bronchitis when taking Nasalcrom? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Bronchitis when taking Nasalcrom? *

What are other drugs people take besides Nasalcrom? *

What are other side effects people have besides Bronchitis? *

Oral Candidiasis (fungal infection of mouth): 6 people, 27.27%
Hypersensitivity: 5 people, 22.73%
Fall: 4 people, 18.18%
Multiple Allergies (allergy to multiple agents): 4 people, 18.18%
Hospitalisation: 4 people, 18.18%
Dyspnea (difficult or laboured breathing): 4 people, 18.18%
Head Injury: 4 people, 18.18%
Hair Loss: 3 people, 13.64%
Fatigue (feeling of tiredness): 3 people, 13.64%
Tendonitis (a condition that causes pain and swelling of tendons): 3 people, 13.64%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 6 people, 27.27%
Hypersensitivity: 3 people, 13.64%
Depression: 2 people, 9.09%
Multiple Myeloma (cancer of the plasma cells): 2 people, 9.09%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 9.09%
Pain: 2 people, 9.09%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.09%
Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi): 2 people, 9.09%
Asthma: 2 people, 9.09%
Stress And Anxiety: 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Nasalcrom and have Bronchitis?

- Check whether Bronchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nasalcrom:

Nasalcrom (1,528 reports)

Bronchitis treatments and more:

Bronchitis (118,921 reports)

Browse all side effects of Nasalcrom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchitis:

Bronchitis (2,328 drugs)

Browse all the conditions that are associated with Bronchitis:

Bronchitis (2,440 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cromolyn sodium (the active ingredients of Nasalcrom) and Nasalcrom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.